QQ客服 官方微博 反馈留言

	Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
	Shi, Leilei; Zhou, Jianfeng; Wu, Jifeng; Shen, Yuemao; Li, Xun
刊名	CURRENT MEDICINAL CHEMISTRY
	2016
卷号	23期号:10页码:1000-1040
关键词	VEGFR-2 inhibitor designing strategy SAR pharmacophore binding mode antiangiogenesis
DOI	10.2174/0929867323666160210130426
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4759812
专题	山东大学
作者单位	Shandong Univ, Sch Pharmaceut Sci, Key Lab Chem Biol, Dept Med Chem,Minist Educ, Jinan 250012, Peoples R China.
推荐引用方式 GB/T 7714	Shi, Leilei,Zhou, Jianfeng,Wu, Jifeng,et al. Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect[J]. CURRENT MEDICINAL CHEMISTRY,2016,23(10):1000-1040.
APA	Shi, Leilei,Zhou, Jianfeng,Wu, Jifeng,Shen, Yuemao,&Li, Xun.(2016).Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect.CURRENT MEDICINAL CHEMISTRY,23(10),1000-1040.
MLA	Shi, Leilei,et al."Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect".CURRENT MEDICINAL CHEMISTRY 23.10(2016):1000-1040.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。